Investigations into the cancer stem cell niche using in-vitro 3-D tumor models and microfluidics.

The concept of Cancer Stem Cells (CSCs) and the CSC Niche/Tumor Microenvironment (TME) as the central driving force behind tumor progression and maintenance has garnered much attention in recent years. Concomitantly, the widespread adoption of 3D tissue models, organotypic co-cultures, and the revolutionary microfluidic technology has resulted in a plethora of ground-breaking fundamental discoveries and has enabled investigations which were previously unfeasible. A large number of existing review papers concern themselves with either a broad look at the TME and CSC Niche, or on the studies undertaken on a particular niche component alone. In this article, we attempt to bring out a harmonic, expansive look at the concept of CSCs, the TME, and the various advancements in answering key biological queries enabled by these emerging new technologies. Our primary goal is to present a fundamental understanding of CSCs, as well as the CSC niche, and elucidate note-worthy examples of investigations being carried out with regard to each of the major TME components, along with our insights into the potential for further research. We hope that this serves as an impetus to new, as well as existing researchers in this area, to gain fresh perspectives on the CSC niche, as well as provide them with a glimpse at the kind of progress being made using 3D tumor models and microfluidic devices.

[1]  Sunitha Nagrath,et al.  Microfluidics and cancer: are we there yet? , 2013, Biomedical microdevices.

[2]  David A. Cheresh,et al.  Role of integrins in cell invasion and migration , 2002, Nature Reviews Cancer.

[3]  J. Nör,et al.  The Perivascular Niche and Self-Renewal of Stem Cells , 2015, Front. Physiol..

[4]  Z. Werb,et al.  The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells? , 2015, Cell stem cell.

[5]  S. Pun,et al.  3-D tissue culture systems for the evaluation and optimization of nanoparticle-based drug carriers. , 2008, Bioconjugate chemistry.

[6]  Linheng Li,et al.  Normal stem cells and cancer stem cells: the niche matters. , 2006, Cancer research.

[7]  A. Pietras Cancer stem cells in tumor heterogeneity. , 2011, Advances in cancer research.

[8]  Jan Paul Medema,et al.  Intra-tumor heterogeneity from a cancer stem cell perspective , 2017, Molecular Cancer.

[9]  M. Mason,et al.  Cancer exosomes trigger mesenchymal stem cell differentiation into pro-angiogenic and pro-invasive myofibroblasts , 2014, Oncotarget.

[10]  Jong-Wan Park,et al.  Oxygen-dependent and -independent regulation of HIF-1alpha. , 2002, Journal of Korean medical science.

[11]  O. Petersen,et al.  Identification of EPSTI1, a novel gene induced by epithelial-stromal interaction in human breast cancer. , 2002, Genomics.

[12]  Ossama Tawfik,et al.  BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt–β-catenin signaling , 2004, Nature Genetics.

[13]  C. Heeschen,et al.  Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. , 2007, Cell stem cell.

[14]  Kenichi Funamoto,et al.  A novel microfluidic platform for high-resolution imaging of a three-dimensional cell culture under a controlled hypoxic environment. , 2012, Lab on a chip.

[15]  O. Yesil‐Celiktas,et al.  Diffusion phenomena of cells and biomolecules in microfluidic devices. , 2015, Biomicrofluidics.

[16]  Qi Wang,et al.  Functional Investigation of NCI-H460-Inducible Myofibroblasts on the Chemoresistance to VP-16 with a Microfluidic 3D Co-Culture Device , 2013, PloS one.

[17]  Q. Sang,et al.  The significance of focal myoepithelial cell layer disruptions in human breast tumor invasion: a paradigm shift from the "protease-centered" hypothesis. , 2004, Experimental cell research.

[18]  Sally Temple,et al.  Endothelial Cells Stimulate Self-Renewal and Expand Neurogenesis of Neural Stem Cells , 2004, Science.

[19]  L. D. Pillis,et al.  A Validated Mathematical Model of Cell-Mediated Immune Response to Tumor Growth , 2005 .

[20]  Ash A. Alizadeh,et al.  Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47 , 2010, Science Translational Medicine.

[21]  Benjamin J. Raphael,et al.  Advances for studying clonal evolution in cancer. , 2013, Cancer letters.

[22]  S. Terry,et al.  Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia. , 2015, American journal of physiology. Cell physiology.

[23]  F. Pampaloni,et al.  The third dimension bridges the gap between cell culture and live tissue , 2007, Nature Reviews Molecular Cell Biology.

[24]  D. Pappas,et al.  Observation of reversible, rapid changes in drug susceptibility of hypoxic tumor cells in a microfluidic device. , 2016, Analytica chimica acta.

[25]  Chu Zhang,et al.  Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cells. , 2009, Biomaterials.

[26]  L. Carrascosa,et al.  Real time and label free profiling of clinically relevant exosomes , 2016, Scientific Reports.

[27]  E. Cukierman,et al.  FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells , 2011, BMC Cancer.

[28]  R. L. Baldwin,et al.  A human ovarian carcinoma murine xenograft model useful for preclinical trials. , 2002, Gynecologic oncology.

[29]  E. Yeh,et al.  Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy , 2016, npj Breast Cancer.

[30]  R. Garofalo,et al.  Oxygen-Independent Stabilization of Hypoxia Inducible Factor (HIF)-1 during RSV Infection , 2008, PloS one.

[31]  N. Forbes,et al.  Microfluidic device for recreating a tumor microenvironment in vitro. , 2011, Journal of visualized experiments : JoVE.

[32]  Haitao Niu,et al.  Overexpression of monocarboxylate anion transporter 1 and 4 in T24-induced cancer-associated fibroblasts regulates the progression of bladder cancer cells in a 3D microfluidic device , 2015, Cell cycle.

[33]  G. Vunjak‐Novakovic,et al.  Recapitulating the Size and Cargo of Tumor Exosomes in a Tissue-Engineered Model , 2016, Theranostics.

[34]  Fei Xing,et al.  Cancer associated fibroblasts (CAFs) in tumor microenvironment. , 2010, Frontiers in bioscience.

[35]  John S. Condeelis,et al.  Chemotaxis in cancer , 2011, Nature Reviews Cancer.

[36]  M. Maharbiz,et al.  Micrometer‐scale oxygen delivery rearranges cells and prevents necrosis in tumor tissue in vitro , 2012, Biotechnology progress.

[37]  A. Sood,et al.  Monocyte subpopulations in angiogenesis. , 2014, Cancer research.

[38]  F. Wang,et al.  Glucose-regulated protein 78 and heparanase expression in oral squamous cell carcinoma: correlations and prognostic significance , 2014, World Journal of Surgical Oncology.

[39]  Kenneth M. Yamada,et al.  Taking Cell-Matrix Adhesions to the Third Dimension , 2001, Science.

[40]  A. Puisieux,et al.  Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition , 2008, PloS one.

[41]  Louis Vermeulen,et al.  Wnt activity defines colon cancer stem cells and is regulated by the microenvironment , 2010, Nature Cell Biology.

[42]  J. Minna,et al.  Stromal and Epithelial Expression of Tumor Markers Hyaluronic Acid and HYAL1 Hyaluronidase in Prostate Cancer* , 2001, The Journal of Biological Chemistry.

[43]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[44]  M. Noble,et al.  Cancer stem cells. , 2006, The New England journal of medicine.

[45]  E. Holland,et al.  Genetically engineered models have advantages over xenografts for preclinical studies. , 2006, Cancer research.

[46]  E. Butcher,et al.  T cell chemotaxis in a simple microfluidic device. , 2006, Lab on a chip.

[47]  Shuichi Takayama,et al.  Quantitative measurement and control of oxygen levels in microfluidic poly(dimethylsiloxane) bioreactors during cell culture , 2007, Biomedical microdevices.

[48]  Till Acker,et al.  Up-regulation of hypoxia-inducible factors HIF-1α and HIF-2α under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function , 2000, Oncogene.

[49]  J. Thiery,et al.  Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer , 2007, Clinical & Experimental Metastasis.

[50]  P. Kim,et al.  Droplet-based microtumor model to assess cell-ECM interactions and drug resistance of gastric cancer cells , 2017, Scientific Reports.

[51]  David J. Beebe,et al.  Understanding the Impact of 2D and 3D Fibroblast Cultures on In Vitro Breast Cancer Models , 2013, PloS one.

[52]  A. Uccelli,et al.  Mesenchymal stem cells in health and disease , 2008, Nature Reviews Immunology.

[53]  Sara Rockwell,et al.  Hypoxia and radiation therapy: past history, ongoing research, and future promise. , 2009, Current molecular medicine.

[54]  Andrew J. Ewald,et al.  Three-dimensional organotypic culture: experimental models of mammalian biology and disease , 2014, Nature Reviews Molecular Cell Biology.

[55]  A. Harris,et al.  The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages , 2000 .

[56]  S. Lim,et al.  Understanding the Roles of FAK in Cancer , 2015, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[57]  J. Dick,et al.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.

[58]  I. Bayazitov,et al.  A perivascular niche for brain tumor stem cells. , 2007, Cancer cell.

[59]  C. Fimognari,et al.  Induction of hypoxia and necrosis in multicellular tumor spheroids is associated with resistance to chemotherapy treatment , 2016, Oncotarget.

[60]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[61]  F. Lin,et al.  Neutrophil migration under spatially-varying chemoattractant gradient profiles , 2015, Biomedical Microdevices.

[62]  L. Prantl,et al.  Limitation of in vivo models investigating angiogenesis in breast cancer. , 2011, Clinical hemorheology and microcirculation.

[63]  C. Michiels,et al.  Tumour hypoxia affects the responsiveness of cancer cells to chemotherapy and promotes cancer progression. , 2008, Anti-cancer agents in medicinal chemistry.

[64]  Paolo A Netti,et al.  An Engineered Breast Cancer Model on a Chip to Replicate ECM‐Activation In Vitro during Tumor Progression , 2016, Advanced healthcare materials.

[65]  Katsuo Kurabayashi,et al.  Emerging Microfluidic Tools for Functional Cellular Immunophenotyping: A New Potential Paradigm for Immune Status Characterization , 2013, Front. Oncol..

[66]  S. Gerecht,et al.  Hypoxia and free radicals: role in tumor progression and the use of engineering-based platforms to address these relationships. , 2015, Free radical biology & medicine.

[67]  R. Kramer,et al.  Invasion of reconstituted basement membrane matrix by metastatic human tumor cells. , 1986, Cancer research.

[68]  Hui Wang,et al.  Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. , 2009, Cancer cell.

[69]  V. Golubovskaya,et al.  Focal adhesion kinase and cancer. , 2009, Histology and histopathology.

[70]  Bingcheng Lin,et al.  Carcinoma-associated fibroblasts promoted tumor spheroid invasion on a microfluidic 3D co-culture device. , 2010, Lab on a chip.

[71]  Irving L Weissman,et al.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. , 2006, Cancer research.

[72]  Jianru Xiao,et al.  Hypoxia activates Wnt/β-catenin signaling by regulating the expression of BCL9 in human hepatocellular carcinoma , 2017, Scientific Reports.

[73]  J. Massagué,et al.  Epithelial-Mesenchymal Transitions Twist in Development and Metastasis , 2004, Cell.

[74]  Byungwook Ahn,et al.  Endothelialized microfluidics for studying microvascular interactions in hematologic diseases. , 2012, Journal of visualized experiments : JoVE.

[75]  Wenming Liu,et al.  Construction of oxygen and chemical concentration gradients in a single microfluidic device for studying tumor cell-drug interactions in a dynamic hypoxia microenvironment. , 2013, Lab on a chip.

[76]  Russell Hughes,et al.  Tumor-associated macrophages: effectors of angiogenesis and tumor progression. , 2009, Biochimica et biophysica acta.

[77]  H. Iishi,et al.  Retaining cell–cell contact enables preparation and culture of spheroids composed of pure primary cancer cells from colorectal cancer , 2011, Proceedings of the National Academy of Sciences.

[78]  Irving L. Weissman,et al.  Association of reactive oxygen species levels and radioresistance in cancer stem cells , 2009, Nature.

[79]  Justin C. Williams,et al.  Microfluidics-based devices: New tools for studying cancer and cancer stem cell migration. , 2011, Biomicrofluidics.

[80]  I. Tannock,et al.  Drug penetration in solid tumours , 2006, Nature Reviews Cancer.

[81]  Liliana Attisano,et al.  Synergistic Cooperation between Hypoxia and Transforming Growth Factor-β Pathways on Human Vascular Endothelial Growth Factor Gene Expression* , 2001, The Journal of Biological Chemistry.

[82]  F. Agani,et al.  Oxygen-independent regulation of HIF-1: novel involvement of PI3K/AKT/mTOR pathway in cancer. , 2013, Current cancer drug targets.

[83]  Sarah E Seton-Rogers Metastasis: Multitasking hyaluronic acid , 2012, Nature Reviews Cancer.

[84]  Chien-Chung Peng,et al.  Generation of oxygen gradients in microfluidic devices for cell culture using spatially confined chemical reactions. , 2011, Lab on a chip.

[85]  M. Clarke,et al.  Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy , 2008, PloS one.

[86]  M. Karin,et al.  Tumor promotion via injury- and death-induced inflammation. , 2011, Immunity.

[87]  Z. Werb,et al.  Matrix Metalloproteinases: Regulators of the Tumor Microenvironment , 2010, Cell.

[88]  J. Rich Cancer stem cells: understanding tumor hierarchy and heterogeneity , 2016, Medicine.

[89]  F. Sotgia,et al.  Cancer stem cell metabolism , 2016, Breast Cancer Research.

[90]  David A. Cheresh,et al.  Integrins in cancer: biological implications and therapeutic opportunities , 2010, Nature Reviews Cancer.

[91]  G. C. Chan,et al.  Microencapsulation of Neuroblastoma Cells and Mesenchymal Stromal Cells in Collagen Microspheres: A 3D Model for Cancer Cell Niche Study , 2015, PloS one.

[92]  S. Gordon,et al.  Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.

[93]  Miguel A. Acosta,et al.  A microfluidic device to study cancer metastasis under chronic and intermittent hypoxia. , 2014, Biomicrofluidics.

[94]  Dietmar W Hutmacher,et al.  Biomaterials offer cancer research the third dimension. , 2010, Nature materials.

[95]  C. Brennan,et al.  Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. , 2010, Cell stem cell.

[96]  Claudia Hoffmann,et al.  Integrating Macrophages into Organotypic Co-Cultures: A 3D In Vitro Model to Study Tumor-Associated Macrophages , 2012, PloS one.

[97]  C. Michiels,et al.  Intermittent hypoxia is a key regulator of cancer cell and endothelial cell interplay in tumours , 2008, The FEBS journal.

[98]  S. Glynn,et al.  Mesenchymal stem cells: key players in cancer progression , 2017, Molecular Cancer.

[99]  C. Haslinger,et al.  Modeling colon adenocarcinomas in vitro a 3D co-culture system induces cancer-relevant pathways upon tumor cell and stromal fibroblast interaction. , 2011, The American journal of pathology.

[100]  M. Simpson,et al.  Emerging roles for hyaluronidase in cancer metastasis and therapy. , 2014, Advances in cancer research.

[101]  Young Seok Kim,et al.  Low production of reactive oxygen species and high DNA repair: mechanism of radioresistance of prostate cancer stem cells. , 2013, Anticancer research.

[102]  Mina J. Bissell,et al.  The perivascular niche regulates breast tumor dormancy , 2013, Nature Cell Biology.

[103]  H. Earp,et al.  Targeting the TAM Receptors in Leukemia , 2016, Cancers.

[104]  A. Phillips,et al.  Hyaluronan Facilitates Transforming Growth Factor-β1-dependent Proliferation via CD44 and Epidermal Growth Factor Receptor Interaction , 2011, The Journal of Biological Chemistry.

[105]  Jianguo Zhang,et al.  high expression of glucose-regulated protein 78 ( grP 78 ) is associated with metastasis and poor prognosis in patients with esophageal squamous cell carcinoma , 2017 .

[106]  A. Harris,et al.  Effects of acute versus chronic hypoxia on DNA damage responses and genomic instability. , 2010, Cancer research.

[107]  L. Qin,et al.  Utilizing a high-throughput microfluidic platform to study hypoxia-driven mesenchymal-mode cell migration. , 2015, Integrative biology : quantitative biosciences from nano to macro.

[108]  F. Su,et al.  Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells , 2011, Molecular Cancer.

[109]  P. Hoff,et al.  Unraveling the role of hypoxia-inducible factor (HIF)-1α and HIF-2α in the adaption process of human microvascular endothelial cells (HMEC-1) to hypoxia: Redundant HIF-dependent regulation of macrophage migration inhibitory factor. , 2018, Microvascular research.

[110]  R. Gillies,et al.  Intermittent Hypoxia Selects for Genotypes and Phenotypes That Increase Survival, Invasion, and Therapy Resistance , 2015, PloS one.

[111]  Raphael Kopan,et al.  The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism , 2009, Cell.

[112]  J. Huse,et al.  Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth. , 2014, Cell stem cell.

[113]  F. Braet,et al.  Planar microfluidic chamber for generation of stable and steep chemoattractant gradients. , 2008, Biophysical journal.

[114]  Kevin J. Harrington,et al.  The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence , 2015, Nature Reviews Cancer.

[115]  Elena Agliari,et al.  Cancer-driven dynamics of immune cells in a microfluidic environment , 2014, Scientific Reports.

[116]  Jos Jonkers,et al.  Genetically engineered mouse models in oncology research and cancer medicine , 2016, EMBO molecular medicine.

[117]  Peter Kuhn,et al.  A rare-cell detector for cancer. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[118]  David J Mooney,et al.  Can tissue engineering concepts advance tumor biology research? , 2010, Trends in biotechnology.

[119]  A. Przylipiak,et al.  Protective influence of hyaluronic acid on focal adhesion kinase activity in human skin fibroblasts exposed to ethanol , 2017, Drug design, development and therapy.

[120]  R. M. Sharrard,et al.  Prostate epithelial cell lines form spheroids with evidence of glandular differentiation in three-dimensional Matrigel cultures , 2001, British Journal of Cancer.

[121]  Raghu Kalluri,et al.  Fibroblasts in cancer , 2006, Nature Reviews Cancer.

[122]  Justin C. Williams,et al.  Evaluation of Cancer Stem Cell Migration Using Compartmentalizing Microfluidic Devices and Live Cell Imaging , 2011, Journal of visualized experiments : JoVE.

[123]  M. Cristofanilli,et al.  Cancer stem cells: implications for cancer therapy. , 2014, Oncology.

[124]  T. Wurdinger,et al.  Microfluidic isolation and transcriptome analysis of serum microvesicles. , 2010, Lab on a chip.

[125]  A. Khademhosseini,et al.  BIOMIMETIC GRADIENT HYDROGELS FOR TISSUE ENGINEERING. , 2010, The Canadian journal of chemical engineering.

[126]  W. Lam,et al.  3D microvascular model recapitulates the diffuse large B-cell lymphoma tumor microenvironment in vitro. , 2017, Lab on a chip.

[127]  David T Eddington,et al.  Precise control over the oxygen conditions within the Boyden chamber using a microfabricated insert. , 2010, Lab on a chip.

[128]  R. Clarkson,et al.  The Complex Nature of Breast Cancer Stem-Like Cells: Heterogeneity and Plasticity , 2013 .

[129]  Z. Trajanoski,et al.  Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. , 2013, Immunity.

[130]  David T Eddington,et al.  Oxygen gradients for open well cellular cultures via microfluidic substrates. , 2010, Lab on a chip.

[131]  Brian Keith,et al.  HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression , 2011, Nature Reviews Cancer.

[132]  J Ratajczak,et al.  Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication , 2006, Leukemia.

[133]  A. Carnero,et al.  The hypoxic microenvironment: A determinant of cancer stem cell evolution , 2016, BioEssays : news and reviews in molecular, cellular and developmental biology.

[134]  Wei Li,et al.  HIF-1α pathway: role, regulation and intervention for cancer therapy , 2015, Acta pharmaceutica Sinica. B.

[135]  Li Ying,et al.  Cancer Associated Fibroblast-Derived Hepatocyte Growth Factor Inhibits the Paclitaxel-Induced Apoptosis of Lung Cancer A549 Cells by Up-Regulating the PI3K/Akt and GRP78 Signaling on a Microfluidic Platform , 2015, PloS one.

[136]  Ji‐Hyun Lee,et al.  Co-Culture of Tumor Spheroids and Fibroblasts in a Collagen Matrix-Incorporated Microfluidic Chip Mimics Reciprocal Activation in Solid Tumor Microenvironment , 2016, PloS one.

[137]  S. Mohanam,et al.  Intermittent Hypoxia Regulates Stem-like Characteristics and Differentiation of Neuroblastoma Cells , 2012, PloS one.

[138]  S. Takayama,et al.  Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[139]  Qi Wang,et al.  Cancer-associated fibroblasts promote non-small cell lung cancer cell invasion by upregulation of glucose-regulated protein 78 (GRP78) expression in an integrated bionic microfluidic device , 2016, Oncotarget.

[140]  Bingcheng Lin,et al.  A microfluidic device for characterizing the invasion of cancer cells in 3‐D matrix , 2009, Electrophoresis.

[141]  Robert A. Weinberg,et al.  Tumor Metastasis: Molecular Insights and Evolving Paradigms , 2011, Cell.

[142]  E. Golemis,et al.  Fibroblast-derived 3D matrix differentially regulates the growth and drug-responsiveness of human cancer cells. , 2008, Matrix biology : journal of the International Society for Matrix Biology.

[143]  A. Halestrap The monocarboxylate transporter family—Structure and functional characterization , 2012, IUBMB Life - A Journal of the International Union of Biochemistry and Molecular Biology.

[144]  P. Hersey,et al.  Glucose-regulated protein 78 antagonizes cisplatin and adriamycin in human melanoma cells. , 2009, Carcinogenesis.

[145]  Amy S. Lee,et al.  Glucose regulated proteins in cancer progression, Drug resistance and immunotherapy , 2006, Cancer biology & therapy.

[146]  S. Zhong,et al.  Exosomes from Drug-Resistant Breast Cancer Cells Transmit Chemoresistance by a Horizontal Transfer of MicroRNAs , 2014, PloS one.

[147]  D. Tuveson,et al.  Dynamics of the immune reaction to pancreatic cancer from inception to invasion. , 2007, Cancer research.

[148]  He Zhu,et al.  A microdevice for multiplexed detection of T-cell-secreted cytokines. , 2008, Lab on a chip.

[149]  Vladimir P Torchilin,et al.  Barriers to drug delivery in solid tumors , 2014, Tissue barriers.

[150]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[151]  B. Rochat Importance of influx and efflux systems and xenobiotic metabolizing enzymes in intratumoral disposition of anticancer agents. , 2009, Current cancer drug targets.

[152]  N. Forbes,et al.  Microfluidic technique to measure intratumoral transport and calculate drug efficacy shows that binding is essential for doxorubicin and release hampers Doxil. , 2013, Integrative biology : quantitative biosciences from nano to macro.

[153]  M. Tsuboi,et al.  Cancer cell invasion driven by extracellular matrix remodeling is dependent on the properties of cancer-associated fibroblasts , 2016, Journal of Cancer Research and Clinical Oncology.

[154]  K. Polyak,et al.  Tumor heterogeneity: causes and consequences. , 2010, Biochimica et biophysica acta.

[155]  G. Whitesides,et al.  Neutrophil chemotaxis in linear and complex gradients of interleukin-8 formed in a microfabricated device , 2002, Nature Biotechnology.

[156]  E. Passegué,et al.  Invasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils , 2015, Proceedings of the National Academy of Sciences.

[157]  A. Orimo,et al.  Carcinoma‐associated fibroblasts: Non‐neoplastic tumour‐promoting mesenchymal cells , 2013, Journal of cellular physiology.

[158]  U. Lendahl,et al.  Notch signaling mediates hypoxia-induced tumor cell migration and invasion , 2008, Proceedings of the National Academy of Sciences.

[159]  P. Pandolfi,et al.  PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo. , 2008, Genes & development.

[160]  A. Karnoub,et al.  Mesenchymal stem cells in tumor development , 2012, Cell adhesion & migration.

[161]  Alberto Mantovani,et al.  Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. , 2006, European journal of cancer.

[162]  Annamaria Gerardino,et al.  Cross talk between cancer and immune cells: exploring complex dynamics in a microfluidic environment. , 2013, Lab on a chip.

[163]  D. Hollywood,et al.  Hypoxia, notch signalling, and prostate cancer , 2013, Nature Reviews Urology.

[164]  L. Vermeulen,et al.  Cancer stem cell niche: the place to be. , 2011, Cancer research.

[165]  Z. Werb,et al.  Extracellular matrix degradation and remodeling in development and disease. , 2011, Cold Spring Harbor perspectives in biology.

[166]  N. Altorki,et al.  Lung inflammation promotes metastasis through neutrophil protease-mediated degradation of Tsp-1 , 2015, Proceedings of the National Academy of Sciences.

[167]  Jian-Long Xiao,et al.  The migration speed of cancer cells influenced by macrophages and myofibroblasts co-cultured in a microfluidic chip. , 2012, Integrative biology : quantitative biosciences from nano to macro.

[168]  C. Gialeli,et al.  Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting , 2011, The FEBS journal.

[169]  L. Xiao,et al.  The cancer-associated fibroblasts and drug resistance. , 2015, European review for medical and pharmacological sciences.

[170]  G. Dienel,et al.  Lactate transport and transporters: General principles and functional roles in brain cells , 2005, Journal of neuroscience research.

[171]  J. Griffin,et al.  Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion , 2009, British Journal of Cancer.

[172]  Carlo C. Maley,et al.  Clonal evolution in cancer , 2012, Nature.

[173]  Brendon M. Baker,et al.  Microfluidics embedded within extracellular matrix to define vascular architectures and pattern diffusive gradients. , 2013, Lab on a chip.

[174]  Yong Wang,et al.  Islet preconditioning via multimodal microfluidic modulation of intermittent hypoxia. , 2012, Analytical chemistry.

[175]  D. Cheresh,et al.  Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance. , 2015, Trends in cell biology.

[176]  C. Blanpain,et al.  Unravelling cancer stem cell potential , 2013, Nature Reviews Cancer.

[177]  R. Germain,et al.  T cell heterogeneity: firmly fixed, predominantly plastic or merely malleable? , 2008, Nature Immunology.

[178]  James R Heath,et al.  Nanotechnology and cancer. , 2008, Annual review of medicine.

[179]  Sharon Gerecht,et al.  Design and development of microbioreactors for long-term cell culture in controlled oxygen microenvironments , 2011, Biomedical Microdevices.

[180]  L. weiswald,et al.  Spherical Cancer Models in Tumor Biology1 , 2015, Neoplasia.

[181]  J. Visvader,et al.  Cancer stem cells in solid tumours: accumulating evidence and unresolved questions , 2008, Nature Reviews Cancer.

[182]  Xin Lu,et al.  Hypoxia and Hypoxia-Inducible Factors: Master Regulators of Metastasis , 2010, Clinical Cancer Research.

[183]  Rong Fan,et al.  A Clinical Microchip for Evaluation of Single Immune Cells Reveals High Functional Heterogeneity in Phenotypically Similar T Cells Nih Public Access Author Manuscript Design Rationale and Detection Limit of the Scbc Online Methods Microchip Fabrication On-chip Secretion Profiling Supplementary Mater , 2022 .

[184]  Karlyne M. Reilly,et al.  Genetically engineered mouse models in cancer research. , 2010, Advances in cancer research.

[185]  W. Farrar,et al.  Radioresistance and Cancer Stem Cells: Survival of the Fittest , 2011 .

[186]  Liju Yang,et al.  Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. , 2014, Assay and drug development technologies.

[187]  D. Hong,et al.  Exosome-mediated drug resistance in cancer: the near future is here , 2016, Therapeutic advances in medical oncology.

[188]  Andreas Trumpp,et al.  Hematopoietic Stem Cells Reversibly Switch from Dormancy to Self-Renewal during Homeostasis and Repair , 2008, Cell.

[189]  P. Dutta,et al.  Hypoxic behavior in cells under controlled microfluidic environment. , 2017, Biochimica et biophysica acta. General subjects.

[190]  R. Weichselbaum,et al.  Glioblastoma cells block radiation‐induced programmed cell death of endothelial cells , 2004, FEBS letters.

[191]  Mark E. Polinkovsky,et al.  Generation of oxygen gradients with arbitrary shapes in a microfluidic device. , 2010, Lab on a chip.

[192]  Xian Xu,et al.  Three-dimensional in vitro tumor models for cancer research and drug evaluation. , 2014, Biotechnology advances.

[193]  R. Kamm,et al.  Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function , 2012, Proceedings of the National Academy of Sciences.

[194]  Andrew J Ewald,et al.  ECM microenvironment regulates collective migration and local dissemination in normal and malignant mammary epithelium , 2012, Proceedings of the National Academy of Sciences.

[195]  Aoife M Shannon,et al.  Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies. , 2003, Cancer treatment reviews.

[196]  M. Tzardi,et al.  Cancer Microenvironment and Inflammation: Role of Hyaluronan , 2015, Front. Immunol..

[197]  M. Bansal,et al.  Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside of the crypt base stem cell niche , 2014, Nature Medicine.

[198]  Donald W Kufe,et al.  Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[199]  N. Itano,et al.  Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment , 2014, Cancers.

[200]  A. Krešo,et al.  Evolution of the cancer stem cell model. , 2014, Cell stem cell.

[201]  L. Bingle,et al.  In vitro study of HIF‐1 activation and VEGF release by bFGF in the T47D breast cancer cell line under normoxic conditions: involvement of PI‐3K/Akt and MEK1/ERK pathways , 2005, The Journal of pathology.

[202]  Ursula Pieper,et al.  A role for matrix metalloproteinases in regulating mammary stem cell function via the Wnt signaling pathway. , 2013, Cell stem cell.

[203]  Nikolay Bazhanov,et al.  Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties , 2010, Proceedings of the National Academy of Sciences.

[204]  R. Sutherland Cell and environment interactions in tumor microregions: the multicell spheroid model. , 1988, Science.